| Financial Year |
March 31 2023 |
| Monetary Funds |
412,538,165.15 |
| Held-for-trading Financial Assets |
54,995,500.00 |
| Notes Receivable |
11,185,945.08 |
| Accounts Receivable |
1,554,990,616.42 |
| Advances to Suppliers |
15,398,487.66 |
| Other Receivables |
22,724,921.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
301,835,902.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,577,670.27 |
| Total Current Assets |
2,445,442,466.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,169,665.42 |
| Investment Properties |
-- |
| Fixed Assetes |
610,867,576.93 |
| Under-construction Projects |
357,247.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
225,546,309.04 |
| R&D expenses |
17,493,827.95 |
| Goodwill |
977,332,230.74 |
| Long-Term Deferred and Prepaid Expenses |
16,926,770.29 |
| Deferred Income Tax Assets |
69,057,489.24 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,344,671,764.01 |
| Total Assets |
4,790,114,230.69 |
| Short-Term Loans |
307,624,097.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
101,226,950.73 |
| Accounts Received In Advance |
8,106,552.86 |
| Employee Compensation Payable |
192,284,103.99 |
| Taxes Payable |
23,570,874.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
208,168,770.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,187,920.01 |
| Other Current Liabilities |
86,266,270.74 |
| Sub-Total of Current Liabilities |
1,068,996,919.81 |
| Long-term Loans |
436,206,499.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
489,935,223.10 |
| Total Liabilities |
1,558,932,142.91 |
| Paid-In Capital(Or Share Stock) |
796,410,841.00 |
| Capital Surplus |
2,933,824,550.64 |
| Surplus Reserve |
79,632,498.72 |
| LESS:Treasury Stock |
191,240,952.40 |
| Undistributed Profits |
-384,515,902.54 |
| Minority Stockholder's Interest |
1,635,636.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,229,546,451.62 |
| Owner's Equity（Stockholder's Equity） |
3,231,182,087.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,790,114,230.69 |
